Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

FDA guidance addresses when device makers need to report changes

Draft guidance from the Food and Drug Administration is seeking to clarify when medical device manufacturers need the agency’s approval to make changes to their products, potentially replacing guidance that had remained unchanged since 1997.

NIH closes drug production facility blamed for contamination issues

The National Institutes of Health (NIH) has permanently closed its facility which manufactured investigational drugs a year after “a series of deficiencies” were found in the unit by Food and Drug Administration (FDA) inspectors.The National Institutes of Health (NIH) has permanently closed its facility which manufactured investigational drugs a year after “a series of deficiencies” were found in the unit by Food and Drug Administration inspectors.

Calif. physicians, hospitals quarrel over nurse-midwives legislation

The California Medical Association (CMA) is opposing a bill which would allow certified nurse-midwives to practice without physician supervision, but not because of the main goal of the legislation, according to Kaiser Health News.

Zika fight continues with insecticide, reproductive research grants

The fight against Zika continued to pick up steam this week after reports of 15 local transmissions in Miami. 

Study: Only 15% of device companies ready for Sept. 24 UDI compliance deadline

A September 24 deadline set by the Food and Drug Administration is looming for Class II medical devices, such as condoms or wheelchairs, to be outfitted with unique device identifier (UDI) barcodes, but in a survey of device makers, only a few said their companies were currently compliant with the standard.

Thumbnail

Q&A with AMDIS Award winner Peter Basch

Recently, the Association of Medical Directors of Information Systems (AMDIS) held their annual awards to recognize leaders in healthcare IT. Among those recipients was Peter Basch, MD, MACP, Senior Director for IT Quality and Safety, Research and National Health IT Policy at MedStar Health.

Senators ask CMS to remove drug abuse treatment from IMD exclusion in Medicaid

In an effort to fight the rise in opioid abuse, 29 U.S. Senators are asking CMS to change Medicaid rules to allow substance treatment facilities with more than 16 beds to be reimbursed when they treat Medicaid beneficiaries over the age of 22.

Thumbnail

Racism leads to proportionally poor mental health for its victims

Exposure to racist or discriminatory behaviors over a lifetime can be harmful to overall mental and physical health, according to a new study in the American Journal of Public Health. Such health detriments are disproportionately heaped upon ethnic and racial minorities (especially people of color in Western countries), because they are more likely to be the subjects of such behaviors.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.